Roundhill GLP-1 & Weight Loss ETF
OZEM
#3029
ETF Rang
€49.72 Mio.
Marktkapitalisierung
🇺🇸 US
Markt
26,59 €
Aktienkurs
-0.65%
Veränderung (1 Tag)
6.07%
Veränderung (1 Jahr)

Roundhill GLP-1 & Weight Loss ETF - Bestände

ETF-Bestände zum Stand 2. Oktober 2026Anzahl der Bestände: 27

Vollständige Bestandsliste

Gewichtung %NameTickerGehaltene Aktien
12.84%
Eli Lilly & CoLLY6323
11.14%
Novo Nordisk A/SNVO168720
7.72%
Pfizer IncPFE155443
6.64%
CSPC Pharmaceutical Group Ltd1093 HK2930000
5.21%
Viking Therapeutics IncVKTX96697
5.08%
Kailera Therapeutics IncKLRA260799
4.66%
Chugai Pharmaceutical Co Ltd4519 JP67500
4.47%
Ascletis Pharma Inc1672 HK2375000
4.38%
Hanmi Pharm Co Ltd128940 KS6768
4.29%
Amgen IncAMGN5971
3.76%
AstraZeneca PLCAZN13509
3.74%
Zealand Pharma A/SZEAL DC55165
3.18%
Roche Holding AGROP SW4286
2.95%
Jiangsu Hengrui Pharmaceuticals Co Ltd1276 HK261600
2.95%
United Laboratories International Holdings Ltd/The3933 HK1644000
2.89%
Hansoh Pharmaceutical Group Co Ltd3692 HK364000
2.51%
Innovent Biologics Inc1801 HK114000
2.33%
Structure Therapeutics IncGPCR45508
2.16%
Gubra A/SGUBRA DC27392
2.05%
MBX Biosciences IncMBX20530
1.85%
Gilead Sciences IncGILD7109
1.47%
Rhythm Pharmaceuticals IncRYTM8890
1.33%
Shionogi & Co Ltd4507 JP41800
0.38%
First American Government Obligations Fund 12/01/2031FGXXX214800.3
0.31%
Wave Life Sciences IncWVE44641
0.17%
Cash & OtherCash&Other95078.78
-0.46%
SWISS FRANCCHF-215321.29